rawfin.tv
Wells Fargo Raises Merck Price Target to $170
MarketsstocksAI Generated

Wells Fargo Raises Merck Price Target to $170

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Wells Fargo & Company has increased its price target for Merck & Co., Inc. (NYSE:MRK) to $170 from $150. The firm maintained an "Overweight" rating, signaling confidence in the pharmaceutical giant's stock performance.

Analyst RatingsPharmaceuticalsStock PriceMerckWells Fargo

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks